Therapeutic Opportunities in Infectious Diseases: Highlights from the Society of Medicines Research Symposium, held on March 14th 2013 at the National Heart & Lung Institute, London, UK [PDF]
Alderton, W K +3 more
core +1 more source
Joint consensus on reducing the burden of invasive meningococcal disease in the Asia-Pacific region. [PDF]
Liu G +13 more
europepmc +1 more source
Invasive Meningococcal Disease in the Post-COVID World: Patterns of Disease Rebound. [PDF]
Findlow J +3 more
europepmc +1 more source
First use of Trumenba (MenB-fHbp) vaccine to control a nursery outbreak of serogroup B invasive meningococcal disease involving children previously immunised with Bexsero (4CMenB), England, November 2023. [PDF]
Foster K +10 more
europepmc +1 more source
Increase in serogroup W invasive meningococcal disease in England associated with pilgrimage to Saudi Arabia, January 2024 to June 2025. [PDF]
Campbell H +9 more
europepmc +1 more source
Market and Non-Market Productivity Losses Associated with Invasive Meningococcal Disease in the USA. [PDF]
Shah HA +9 more
europepmc +1 more source
Outbreak of invasive meningococcal disease caused by a meningococcus serogroup B expressing a rare <i>porA</i> genosubtype (19-54, 15), Spain, March to April 2024. [PDF]
Abad R +12 more
europepmc +1 more source
Epidemiology of invasive meningococcal disease, Japan, 2013 to 2023. [PDF]
Kobayashi M +6 more
europepmc +1 more source
Twenty-Eight Years of Invasive Meningococcal Disease Surveillance in the Autonomous Province of Vojvodina, Serbia: Epidemiological Trends and Implications for Enhanced Surveillance and Vaccination Policy. [PDF]
Ristić M +5 more
europepmc +1 more source

